Skip to main content
. 2024 Dec 3;22:750. doi: 10.1186/s12951-024-03027-w

Scheme 1.

Scheme 1

Diagram outlining the preparation of small molecular self-assembly FU-SS-IND NPs and the use of FU-SS-IND NPs for robust GSH exhaustion and tumor-specific immunotherapy. Combining FU-SS-IND NPs with PD-L1 mAb further maximizes tumor inhibition